In December 2022, the European Commission’s Directorate-General for Health and Food Safety (DG SANTE) - via the European Health and Digital Executive Agency (HaDEA) - has contracted a “Study supporting the monitoring of availability of medical devices on the EU market” to a consortium led by the Austrian National Public Health Institute (Gesundheit Österreich GmbH / GÖG), in collaboration with Areté and Civic Consulting. The study will be running for 36 months (December 2025).
Objective and consultation activities
The general objective of the study is to monitor and analyse the availability of medical devices on the EU market in the context of the implementation of Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 on in vitro diagnostic medical devices.
To that purpose, relevant stakeholders will be mapped and consulted, and information needs as well as data sources will be identified. The study team will also design and establish a dashboard to gather the data retrieved and, based on feedback received, identify obstacles that could affect availability of devices and/or impair the conformity assessment process, pointing to potential solutions. The study requires therefore the contractor to approach stakeholders for several consultation activities, including surveys and interviews.
Working definitions of terms for the "Study supporting the monitoring of availability of medical devices on the EU market"
Should you have any questions, please do not hesitate to contact the study’s Project Manager Friederike Windisch (firstname.lastname@example.org).